HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Expression and function of adenosine receptors in the chinchilla cochlea.

Abstract
Previous studies indicate the presence of adenosine receptors in the cochlear tissues obtained from different animals. This study was initiated to determine the subtypes of adenosine receptor (AR) present in the chinchilla cochlea and to assess their function. Radioligand binding studies demonstrate the presence of both the A1AR and A3AR in membranes prepared from the cochlea, using the radioligands [3H]DPCPX and [125I]APNEA. Estimates of the number (Bmax) of A1AR and A1AR plus A3AR by saturation curves were 118 +/- 13 and 417 +/- 120 fmol/mg, respectively, with the respective equilibrium dissociation constants (Kd) averaging 2.7 +/- 0.2 and 26.3 +/- 13.8 nM. No significant number of A2aAR were detected using [3H]CGS21680. The nonhydrolyzable adenosine analog R-phenylisopropyladenosine (R-PIA, 1 microM) elicited a small but significant degree of inhibition of forskolin-stimulated adenylyl cyclase activity (10.4 +/- 2.5%) in cochlear membrane preparations, which was insensitive to blockade by theophylline (100 microM). Furthermore, R-PIA elicited an increase in inositol 1,4,5-trisphosphate production in dissociated cell preparations obtained from the cochlea. No significant effect of R-PIA was observed on auditory measures such as auditory brainstem evoked response, cochlear action potential and endocochlear potential following round window application. However, round window application of R-PIA elicited significant increases in the activities of antioxidant enzymes such as superoxide dismutase and glutathione peroxidase and significantly reduced the levels of malondialdehyde, a marker of lipid peroxidation. These results suggest a potential cytoprotective role of adenosine in the cochlea against oxidative damage.
AuthorsM S Ford, S B Maggirwar, L P Rybak, C Whitworth, V Ramkumar
JournalHearing research (Hear Res) Vol. 105 Issue 1-2 Pg. 130-40 (Mar 1997) ISSN: 0378-5955 [Print] NETHERLANDS
PMID9083810 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • N(6)-2-(4-aminophenyl)ethyladenosine
  • Phenethylamines
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Receptors, Purinergic P1
  • Xanthines
  • 1,3-dipropyl-8-cyclopentylxanthine
  • 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
  • Phenylisopropyladenosine
  • Malondialdehyde
  • Inositol 1,4,5-Trisphosphate
  • Catalase
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • Glutathione Reductase
  • Adenosine
Topics
  • Adenosine (analogs & derivatives, metabolism)
  • Animals
  • Binding, Competitive
  • Blotting, Western
  • Catalase (metabolism)
  • Chinchilla
  • Cochlea (cytology, drug effects, metabolism)
  • Cochlear Microphonic Potentials (drug effects)
  • Electrophoresis, Polyacrylamide Gel
  • Evoked Potentials, Auditory, Brain Stem (drug effects)
  • Glutathione Peroxidase (metabolism)
  • Glutathione Reductase (metabolism)
  • Inositol 1,4,5-Trisphosphate (metabolism)
  • Lipid Peroxidation (drug effects)
  • Malondialdehyde (metabolism)
  • Oxidative Stress (drug effects)
  • Phenethylamines (metabolism)
  • Phenylisopropyladenosine (metabolism, pharmacology)
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Radioligand Assay
  • Receptors, Purinergic P1 (metabolism, physiology)
  • Round Window, Ear (drug effects)
  • Superoxide Dismutase (metabolism)
  • Xanthines (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: